Keywords: ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; BMI; body mass index; CKD; chronic kidney disease; ICD; implantable cardioverter-defibrillator; LVEF; left ventricular ejection fraction; NYHA; New York Heart Association;